demonstrated that treatment with andrographolide notably reduces the nuclear localization of NF-κB by modulating the PKA/PP2A/IKK axis in a cisplatin-resistant human HCC cell line (HepG2CR) [389]. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.